INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAB4 Class: CONV BD US

ADVENT CAPITAL MANAGEMENT /DE/'s Holding History (CIK: 0001097278)

Note: Option positions (PUT/CALL) are excluded.

Q3 2020
Shares 18,604,000 Value ($000) $12,963 Avg Close Range
Q2 2020
Shares 16,703,000 Value ($000) $12,060 Avg Close Range
Q1 2020
Shares 16,582,000 Value ($000) $14,449 Avg Close Range
Q4 2019
Shares 2,500,000 Value ($000) $3,317 Avg Close Range